Dr. Rodney Guttmann has a PH.D. in Pharmacology from the University of Alabama at Birmingham. Dr. Guttmann's research includes biomarker assay development with a major focus on Alzheimer’s disease and neurodegeneration. Other work in the lab involves the development of small bioactive peptides with potential clinical or research uses. PH.D. Pharmcology, University of Alabama at Birmingham

Dr. Guttmann research includes biomarker assay development with a major focus on Alzheimer’s disease and neurodegeneration. Other work in the lab involves the development of small bioactive peptides with potential clinical or research uses.